000 | 01829 a2200541 4500 | ||
---|---|---|---|
005 | 20250513091743.0 | ||
264 | 0 | _c19960930 | |
008 | 199609s 0 0 eng d | ||
022 | _a0888-7543 | ||
024 | 7 |
_a10.1006/geno.1996.0329 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRassool, F V | |
245 | 0 | 0 |
_aDirect cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. _h[electronic resource] |
260 |
_bGenomics _cJul 1996 |
||
300 |
_a109-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAphidicolin _xpharmacology |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBlotting, Southern |
650 | 0 | 4 | _aChromosome Fragile Sites |
650 | 0 | 4 | _aChromosome Fragility |
650 | 0 | 4 | _aChromosome Walking |
650 | 0 | 4 |
_aChromosomes, Artificial, Yeast _xgenetics |
650 | 0 | 4 |
_aChromosomes, Human, Pair 3 _xdrug effects |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 |
_aDNA _xgenetics |
650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aNucleic Acid Synthesis Inhibitors |
650 | 0 | 4 | _aRecombination, Genetic |
650 | 0 | 4 | _aSequence Deletion |
650 | 0 | 4 | _aTrinucleotide Repeats |
700 | 1 | _aLe Beau, M M | |
700 | 1 | _aShen, M L | |
700 | 1 | _aNeilly, M E | |
700 | 1 | _aEspinosa, R | |
700 | 1 | _aOng, S T | |
700 | 1 | _aBoldog, F | |
700 | 1 | _aDrabkin, H | |
700 | 1 | _aMcCarroll, R | |
700 | 1 | _aMcKeithan, T W | |
773 | 0 |
_tGenomics _gvol. 35 _gno. 1 _gp. 109-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/geno.1996.0329 _zAvailable from publisher's website |
999 |
_c8659980 _d8659980 |